Gilead Sciences, Inc. (NASDAQ:GILD) Announces Quarterly Dividend of $0.82
One daysingle sourceOne outlet reported this, in 2 reports over 1 day - no second voice in this corpus.
All 2 reports on Wed, 5 August 2026
What it is about
Wealth Preservation AdvisorsStrategic Investment Solutions IncDividend History For Gilead SciencesQuattro AdvisorsInstitutional Trading Of Gilead SciencesGilead Sciences StockGilead SciencesAres Financial ConsultingNews Ratings For Gilead Sciences DailyVermillion White Wealth Management GroupNasdaqFoster City, California, United StatesCalifornia, United StatesGilead Sciences News SummaryHedge Funds Weigh In On Gilead SciencesCantor FitzgeraldGoldman Sachs GroupNeedham CompanyInsider Transactions At Gilead SciencesGilead Sciences Stock Down
Who published it, and when
original reportfirst to report
tickerreport.com
5 Aug, 11:03over 3 hours5 Aug, 14:10
How it spread - 2 original reports
Wed, 5 August 2026
2 reports- tickerreport.com11:03first to report
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) declared a quarterly dividend on Tuesday, August 4th. Shareholders of record on Tuesday, September 15th will be paid a dividend of 0.82 per share by the biopharmaceutical company on Tuesday, September 29th. This represents a c) dividend on an annualized basis and a dividend yield of 2.4%. […]
- tickerreport.com14:10
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price raised by research analysts at Royal Bank Of Canada from $120.00 to $123.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has a “sector perform” rating on the biopharmaceutical company’s stock. Royal Bank Of Canada’s price objective suggests a potential downside […]